US plan to fight Alzheimer’s includes funding for development of insulin nasal spray

US Health and Human Services Secretary Kathleen Sebelius has announced a national plan to fight Alzheimer’s disease that includes almost $8 million in funding for research related to an insulin nasal spray for the treatment of the disease. An article published in the Archives of Neurology in September 2011 described positive results from the SNIFF (Study of Nasal Insulin to Fight Forgetfulness) study of nasal insulin for the treatment of Alzheimers.

The Obama administration announced in February 2012 that it would make funding available to support research for Alzheimer’s treatments in fiscal year 2012. “These actions are the cornerstones of an historic effort to fight Alzheimer’s disease. This is a national plan—not a federal one, because reducing the burden of Alzheimer’s will require the active engagement of both the public and private sectors,” said Secretary Sebelius.

Read the HHS press release.

Share

published on

May 10-May 14RDD 2026, Phoenix, AZ, USA

May 15-May 16: ATS Respiratory Innovation Summit 2026, Orlando, FL, USA

May 17-May 20: ATS International Conference 2026, Orlando, FL, USA

June 10SMI.London 2026, London, UK

July 13-July 162026 ISAM Congress, Taipei, Taiwan